These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11356794)

  • 1. Systemic and lung physiological changes in rats after intravascular activation of complement.
    Younger JG; Sasaki N; Delgado J; Ko AC; Nghiem TX; Waite MD; Till GO; Ward PA
    J Appl Physiol (1985); 2001 Jun; 90(6):2289-95. PubMed ID: 11356794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.
    Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM
    J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effects of complement activation in hemorrhagic shock.
    Younger JG; Sasaki N; Waite MD; Murray HN; Saleh EF; Ravage ZB; Hirschl RB; Ward PA; Till GO
    J Appl Physiol (1985); 2001 Feb; 90(2):441-6. PubMed ID: 11160040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of complement activation with cobra venom factor on pulmonary vascular permeability.
    Johnson A; Cooper JA; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2202-9. PubMed ID: 3027023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic complement activation, lung injury, and products of lipid peroxidation.
    Ward PA; Till GO; Hatherill JR; Annesley TM; Kunkel RG
    J Clin Invest; 1985 Aug; 76(2):517-27. PubMed ID: 4031060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosanoids are involved in the permeability changes but not the pulmonary hypertension after systemic activation of complement.
    Morganroth ML; Till GO; Schoeneich S; Ward PA
    Lab Invest; 1988 Mar; 58(3):316-23. PubMed ID: 2831433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and neutrophil-mediated injury of perfused rat lungs.
    Morganroth ML; Till GO; Kunkel RG; Ward PA
    Lab Invest; 1986 May; 54(5):507-14. PubMed ID: 3702342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats.
    Proctor LM; Strachan AJ; Woodruff TM; Mahadevan IB; Williams HM; Shiels IA; Taylor SM
    Int Immunopharmacol; 2006 Aug; 6(8):1224-32. PubMed ID: 16782534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
    Till GO; Morganroth ML; Kunkel R; Ward PA
    Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic complement activation and acute lung injury.
    Till GO; Ward PA
    Fed Proc; 1986 Jan; 45(1):13-8. PubMed ID: 3940902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.
    Crawford MH; Grover FL; Kolb WP; McMahan CA; O'Rourke RA; McManus LM; Pinckard RN
    Circulation; 1988 Dec; 78(6):1449-58. PubMed ID: 3191598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CVF-induced decomplementation: effect on lung transvascular protein flux after thrombin.
    Johnson A; Lo SK; Blumenstock FB; Malik AB
    J Appl Physiol (1985); 1987 Mar; 62(3):863-9. PubMed ID: 3032888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antigen-induced bronchoconstriction after intravascular complement activation with cobra venom factor. Reversal by granulocyte depletion.
    Regal JF; Fraser DG; Anderson DE; Solem LE
    J Immunol; 1993 Apr; 150(8 Pt 1):3496-505. PubMed ID: 8468484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravascular complement activation and brief episodes of hypoxia on protein in bronchoalveolar lavage fluid in C5 sufficient and deficient mice.
    Larsen GL; Presley DM; Graves JP; Giclas PC
    Pediatr Pulmonol; 1991; 11(4):302-9. PubMed ID: 1758754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.
    Till GO; Johnson KJ; Kunkel R; Ward PA
    J Clin Invest; 1982 May; 69(5):1126-35. PubMed ID: 7068850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of lung reactions after complement depletion during dialysis: an experimental study in pigs.
    Blomquist S; Malmros C; Mårtensson L; Thörne J
    Artif Organs; 1991 Oct; 15(5):397-401. PubMed ID: 1741685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury.
    Ward PA; Till GO; Kunkel R; Beauchamp C
    J Clin Invest; 1983 Sep; 72(3):789-801. PubMed ID: 6886005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular injury and proteinuria in rats after intrarenal injection of cobra venom factor. Evidence for the role of neutrophil-derived oxygen free radicals.
    Rehan A; Wiggins RC; Kunkel RG; Till GO; Johnson KJ
    Am J Pathol; 1986 Apr; 123(1):57-66. PubMed ID: 2421581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
    Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of systemic decomplementation with cobra venom factor on corneal complement levels in guinea pigs.
    Pleyer U; Mondino BJ; Sumner HL
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2212-5. PubMed ID: 1607231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.